Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for INSULIN GLULISINE RECOMBINANT
- Degludec Glargine U300 Hospital Study
- The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.
- Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal
- Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM
- Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy
- A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients
- Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
- A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus
- Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.
- Insulin Dose Adjustments for Meals Differing in Fat Content in T1DM
- Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
- Investigation of the Safety of Intranasal Glulisine in Down Syndrome
- Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)
- Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in Paraguay
- Normal Versus Dual Wave Insulin Bolus for High-protein Food
- Effect of LIXIsenatide on the Renal System
- Linagliptin Inpatient Trial
- Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM
- CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)
- Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients
- Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
- Liraglutide in the Treatment of Type 1 Diabetes Mellitus
- Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus
- Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
- Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
- Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use
- Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.
- Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study
- Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)
- baSal BoluS Therapy in patIenTs With TypE 1 Diabetes Mellitus
- Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs
- Apidra Children & Adolescents Study
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
- Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart
- Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial
- Diabetes in the Elderly: Prospective Study
- Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.
- Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study
- INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes
- Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition
- Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting
- Self Titration With Apidra to Reach Target Study (START)
- A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone
- Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
- Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers
- Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients
- Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus
- Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia
- Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult Controls
- The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children
- Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
- Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes
- Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction
- Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin
- Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus
- Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery
- Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
- Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)
- Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes
- Glulisine + Lantus in Type I Patients
- Glulisine + Lantus in Type I Patients
- Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study
- Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes Mellitus
- APIDRA Registration Study
- Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
- Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus
- Insulin Glulisine, Diabetes Mellitus Type 1
- Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes
- Insulin Glargine "All to Target" Trial
- Dose-Exposure-Response in Type 1 Diabetes Mellitus
- Insulin Glulisine in Type 2 Diabetic Patients
- Insulin Glulisine in Healthy Lean and Obese Subjects
- Insulin Glulisine in Type 2 Diabetes Mellitus
- Insulin Glulisine in Type 1 Diabetes Mellitus
- Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus
- Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus
- Glulisine Pre- and Postmeal
- Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
- ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.
- OPAL - Insulin Glulisine, Diabetes Mellitus
- Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients
- Insulin Glulisine in Diabetes Mellitus, Type 2
- Opposing Step-by-step Insulin Reinforcement to Intensified Strategy
- Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)
- Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin
- Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus
- Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin
- Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents
Clinical trials list
click for details